Literature DB >> 9434156

Cloning of a new Kunitz-type protease inhibitor with a putative transmembrane domain overexpressed in pancreatic cancer.

F Müller-Pillasch1, C Wallrapp, K Bartels, G Varga, H Friess, M Büchler, G Adler, T M Gress.   

Abstract

In a previous large scale screen for differentially expressed genes in pancreatic cancer, we identified a gene highly overexpressed in cancer encoding a novel putative transmembrane protein with two Kunitz-type serine protease inhibitor domains. The identified gene named kop (Kunitz domain containing protein overexpressed in pancreatic cancer) was assigned to chromosome 19 in the region 19q13.1. Kop was detected at high levels in pancreatic cancer cell lines and was overexpressed in pancreatic cancer tissues as compared to both, normal pancreas and chronic pancreatitis tissues. Being a member of the Kunitz-type serine protease inhibitor family, this new gene may participate in tumour cell invasion and metastasis and in the development of the marked desmoplastic reaction typical for human pancreatic cancer tissues. In this context, the fact that kop has a putative transmembrane domain may have functional implications of particular interest.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9434156     DOI: 10.1016/s0167-4781(97)00129-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.

Authors:  Roman Szabo; John P Hobson; Karin List; Alfredo Molinolo; Chen-Yong Lin; Thomas H Bugge
Journal:  J Biol Chem       Date:  2008-08-19       Impact factor: 5.157

2.  HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase.

Authors:  C-H Tsai; C-H Teng; Y-T Tu; T-S Cheng; S-R Wu; C-J Ko; H-Y Shyu; S-W Lan; H-P Huang; S-F Tzeng; M D Johnson; C-Y Lin; P-W Hsiao; M-S Lee
Journal:  Oncogene       Date:  2013-10-14       Impact factor: 9.867

3.  Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells.

Authors:  Nick Devoogdt; Gholamreza Hassanzadeh Ghassabeh; Jing Zhang; Lea Brys; Patrick De Baetselier; Hilde Revets
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

4.  Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities.

Authors:  Amandine Bemmo; Christel Dias; April A N Rose; Caterina Russo; Peter Siegel; Jacek Majewski
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

5.  Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality.

Authors:  Roman Szabo; Peter Kosa; Karin List; Thomas H Bugge
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

6.  Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitro.

Authors:  Ludovica Bruno; Reinhard Hoffmann; Fraser McBlane; John Brown; Rajeev Gupta; Chirag Joshi; Stella Pearson; Thomas Seidl; Clare Heyworth; Tariq Enver
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

7.  Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers.

Authors:  Cindy M Yamamoto; Melanie L Oakes; Taku Murakami; Michael G Muto; Ross S Berkowitz; Shu-Wing Ng
Journal:  J Ovarian Res       Date:  2018-03-02       Impact factor: 4.234

8.  Metastatic progression and gene expression between breast cancer cell lines from African American and Caucasian women.

Authors:  Haile F Yancy; Jacquline A Mason; Sharla Peters; Charles E Thompson; George K Littleton; Marti Jett; Agnes A Day
Journal:  J Carcinog       Date:  2007-05-01

9.  Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea.

Authors:  Nicolas Faller; Ivan Gautschi; Laurent Schild
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

10.  Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells.

Authors:  Koji Yamamoto; Makiko Kawaguchi; Takeshi Shimomura; Aya Izumi; Kazuomi Konari; Arata Honda; Chen-Yong Lin; Michael D Johnson; Yoshihiro Yamashita; Tsuyoshi Fukushima; Hiroaki Kataoka
Journal:  Oncotarget       Date:  2018-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.